Castelli Jeff's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Dec 20, 2023
- Accession no.
- 0000950170-23-071911
- Filed
- Dec 20, 2023
- Trade date
- Dec 18-20, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $253.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Castelli JeffCIK 0001569225 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | AGrant or awardAcquired | +8,643 | $0.00 | $0 | 377,236 | Direct | |
| Dec 19, 2023 | Common Stock | SSaleDisposed | −17,500 | $13.25 | −$231,875 | 359,736 | Direct | |
| Dec 20, 2023 | Common Stock | SSaleDisposed | −1,654 | $13.10 | −$21,667.4 | 358,082 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.